repaglinide has been researched along with ascorbic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bindu, B; Manikandan, A; Vijayalakshmi, S | 1 |
| Bojarska-Junak, A; Gumieniczek, A; Hopkała, H; Roliński, J | 1 |
1 review(s) available for repaglinide and ascorbic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for repaglinide and ascorbic acid
| Article | Year |
|---|---|
Synthesis and discovery of triazolo-pyridazine-6-yl-substituted piperazines as effective anti-diabetic drugs; evaluated over dipeptidyl peptidase-4 inhibition mechanism and insulinotropic activities.
Topics: Diabetes Mellitus; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Drug Discovery; Humans; Hypoglycemic Agents; Insulin; Molecular Structure; Piperazines; Pyridazines; Structure-Activity Relationship; Triazoles | 2020 |
Antioxidative and anti-inflammatory effects of repaglinide in plasma of diabetic animals.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Ascorbic Acid; Blood Glucose; Carbamates; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Insulin; Piperidines; Rabbits | 2005 |